TheBodyPro: Hefty new study takes on weight conundrum in HIV care - and its answers are complicated
A new retrospective study of over 32,000 patients indicates that certain integrase inhibitors used in HIV treatment are linked to increased body weight. The findings highlight complex variations in outcomes, particularly noting specific impacts on Black women.
Why it matters
Understanding the side effects of antiretroviral therapy is crucial for improving long-term health outcomes and patient adherence for those living with HIV.
The latest major study exploring the role of antiretrovirals in weight gain has arrived — and its findings don’t fit neatly into either side of the debate. A new, massive analysis out of the U.S. appears to affirm that, on balance, some integrase inhibitors do have a larger impact on body weight than other drugs. But the devil is very much in the details — and those details include an important signal regarding Black women in particular, as well as some important takeaways for how we can best broach this subject with all of our patients living with HIV.
The article reports on medical research findings without taking a political stance or using loaded language.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in